Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2026 09:00 ET | Source: Junshi Biosciences

Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications

NDAs for Toripalimab Injection (Subcutaneous) Across 12 Indications accepted by the NMPA